Holm R, Høie J, Kaalhus O, Nesland J M
Department of Pathology, Norwegian Radium Hospital, Oslo, Norway.
Virchows Arch. 1995;427(3):289-94. doi: 10.1007/BF00203397.
Reduced expression of nm23/NDP kinase and increased expression of cathepsin D seem to be correlated with the high metastatic potential in a variety of malignancies. The expression of nm23/NDP kinase and that of cathepsin D have been evaluated by means of an immunohistochemical technique in paraffin-embedded tissues from 44 primary medullary carcinomas of the thyroid gland (MCT) and from the corresponding lymph node metastases in 32 of these cases. In addition, lymph node metastases from 4 cases were studied. We found that 36 of 44 (82%) primary and 26 of 36 (72%) lymph node metastatic MCT were nm23/NDP kinase positive, whereas 14 of the 44 (32%) primary and 17 of the 36 (47%) lymph node metastatic MCT were cathepsin D positive. We found no indication that the nm23/NDP kinase level has any prognostic significance in MCT. The cathepsin D level is close to being prognostically significant in this study, and we cannot exclude the possibility that it could be of prognostic value. However, it seems to be quite weak, and therefore of little use in a clinical situation.
nm23/NDP激酶表达降低和组织蛋白酶D表达增加似乎与多种恶性肿瘤的高转移潜能相关。采用免疫组化技术对44例原发性甲状腺髓样癌(MCT)石蜡包埋组织及其32例相应淋巴结转移灶中nm23/NDP激酶和组织蛋白酶D的表达进行了评估。此外,还研究了4例患者的淋巴结转移情况。我们发现,44例原发性MCT中有36例(82%)、36例淋巴结转移MCT中有26例(72%)nm23/NDP激酶呈阳性,而44例原发性MCT中有14例(32%)、36例淋巴结转移MCT中有17例(47%)组织蛋白酶D呈阳性。我们未发现nm23/NDP激酶水平对MCT有任何预后意义的迹象。在本研究中,组织蛋白酶D水平接近具有预后意义,我们不能排除其可能具有预后价值的可能性。然而,其相关性似乎相当弱,因此在临床情况下几乎没有用处。